- Home
- BNT vs EXEL Comparison
BNT vs EXEL Comparison
Compare BNT & EXEL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | BNT | EXEL |
|---|---|---|
| Founded | 2020 | 1994 |
| Country | Bermuda | United States |
| Employees | N/A | N/A |
| Industry | | Biotechnology: Biological Products (No Diagnostic Substances) |
| Sector | | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 10.9B | 12.7B |
| IPO Year | 2020 | 2000 |
Fundamental Metrics
Financial Performance| Metric | BNT | EXEL |
|---|---|---|
| Price | $42.28 | $73.18 |
| Analyst Decision | | Buy |
| Analyst Count | 0 | 17 |
| Target Price | N/A | ★ $61.36 |
| AVG Volume (30 Days) | 6.9K | ★ 2.5M |
| Earning Date | 11-16-2026 | 10-29-2026 |
| Dividend Yield | ★ 0.69% | N/A |
| EPS Growth | N/A | ★ 57.95 |
| EPS | N/A | ★ 2.46 |
| Revenue | N/A | ★ $452,477,000.00 |
| Revenue This Year | N/A | $10.14 |
| Revenue Next Year | N/A | $12.56 |
| P/E Ratio | ★ $19.14 | $29.26 |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $35.62 | $39.71 |
| 52 Week High | $49.86 | $73.44 |
Technical Indicators
Market Signals| Indicator | BNT | EXEL |
|---|---|---|
| Relative Strength Index (RSI) | 66.46 | 85.67 |
| Support Level | $40.28 | $54.85 |
| Resistance Level | $41.40 | N/A |
| Average True Range (ATR) | 0.71 | 1.93 |
| MACD | 0.49 | 0.70 |
| Stochastic Oscillator | 79.24 | 90.71 |
Price Performance
Historical ComparisonAbout BNT Brookfield Wealth Solutions Ltd.
Brookfield Wealth Solutions Ltd, formerly Brookfield Reinsurance Ltd operates a capital solutions business providing insurance and reinsurance services to individuals and institutions. Through its subsidiary, the company offers a broad range of insurance products and services, including life insurance and annuities, and personal and commercial property and casualty insurance. The Company's reporting segments are Annuities, P&C, Life Insurance and Corporate and Other. Majority revenue is generated from Annuities segment followed by P&C.
About EXEL Exelixis Inc.
Exelixis Inc is a biopharmaceutical firm that discovers, develops, and commercializes treatments for cancer. Its molecule, cabozantinib, is indicated for the treatment of patients with metastatic medullary thyroid cancer under the name Cometriq and for the treatment of kidney and liver cancer under the name Cabometyx. Exelixis and its partner Roche have also brought Cotellic to market for the treatment of melanoma.